Patents by Inventor Jean-Christophe Audonnet

Jean-Christophe Audonnet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10363300
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: July 30, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Jean-Christophe Audonnet, Frédéric Reynard, Natalia Bomchil, Cécile Sigoillot-Claude
  • Patent number: 10350287
    Abstract: The present invention provides vectors that contain and express in vivo or in vitro one or more Hendra virus polypeptides or antigens that elicit an immune response in animal or human against Hendra virus and Nipah virus, compositions comprising said vectors and/or Hendra virus polypeptides, methods of vaccination against Hendra virus and Nipah virus, and kits for use with such methods and compositions.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: July 16, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Jean-Christophe Audonnet, Jules Maarten Minke, Teshome Mebatsion, Catherine Charreyre
  • Patent number: 10125401
    Abstract: The present invention relates to methods of differentiating and characterizing IBV, CSFV and NDV strains, and identifying new strains using high resolution melt technology. The present invention also provides primers and kits for use with such methods.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: November 13, 2018
    Assignee: ASIA-PACIFIC SPECIAL NUTRIENTS SDN. BHD.
    Inventors: Jean-Christophe Audonnet, Seetha Jaganathan
  • Patent number: 10076566
    Abstract: The present invention provides vectors that contain and express in vivo or in vitro CDV polypeptides or antigens that elicit an immune response in animal against CDV, compositions comprising said vectors and/or CDV polypeptides, and methods of vaccination against CDV. The invention further provides methods for inducing an immunogenic or protective response against CDV and other canine virus, as well as methods for preventing or treating CDV and other canine virus or disease state(s) caused by CDV and other canine virus.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: September 18, 2018
    Assignee: Merial Inc.
    Inventors: Jean-Christophe Audonnet, Jules Minke
  • Publication number: 20180236056
    Abstract: The invention provides novel methods and compositions for the vaccination of porcine animals against porcine reproductive and respiratory syndrome virus (PRRSV). Described herein are immunological and/or vaccine compositions comprising a DNA vector encoding a PRRSV protein, particularly a truncated ORF7 protein, which are administered to porcines using needle-free delivery. The plasmid can include more than one nucleic acid molecule such that the plasmid can express more than one antigen. Also disclosed are methods for using and kits employing such compositions.
    Type: Application
    Filed: April 27, 2017
    Publication date: August 23, 2018
    Applicants: MERIAL INC., CHULALONGKORN UNIVERSITY
    Inventors: Sanipa Suradhat, Jean-Christophe Audonnet, Catherine Charreyre
  • Patent number: 10010605
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: July 3, 2018
    Assignee: Merial, Inc.
    Inventors: Jean-Christophe Audonnet, Zahia Hannas-Djebbara, Teshome Mebatsion, Yu-Wei Chiang, Justin Widener, Frédéric Reynard
  • Publication number: 20180169216
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
    Type: Application
    Filed: February 5, 2018
    Publication date: June 21, 2018
    Applicant: MERIAL INC.
    Inventors: Jean-Christophe Audonnet, Frédéric Reynard, Natalia Bomchil, Cécile Sigoillot-Claude
  • Patent number: 9913891
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: March 13, 2018
    Assignee: MERIAL INC.
    Inventors: Jean-Christophe Audonnet, Frédéric Reynard, Natalia Bomchil, Cécile Sigoillot-Claude
  • Patent number: 9669085
    Abstract: The invention provides novel methods and compositions for the vaccination of porcine animals against porcine reproductive and respiratory syndrome virus (PRRSV). Described herein are immunological and/or vaccine compositions comprising a DNA vector encoding a PRRSV protein, particularly a truncated ORF7 protein, which are administered to porcines using needle-free delivery. The plasmid can include more than one nucleic acid molecule such that the plasmid can express more than one antigen. Also disclosed are methods for using and kits employing such compositions.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: June 6, 2017
    Assignees: MERIAL INC., Chulalongkorn University
    Inventors: Sanipa Suradhat, Jean-Christophe Audonnet, Catherine Charreyre
  • Publication number: 20170143819
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 25, 2017
    Applicant: MERIAL INC.
    Inventors: Jean-Christophe Audonnet, Frédéric Reynard, Natalia Bomchil, Cécile Sigoillot-Claude
  • Publication number: 20170087242
    Abstract: The present invention provides vectors that contain and express in vivo or in vitro one or more Hendra virus polypeptides or antigens that elicit an immune response in animal or human against Hendra virus and Nipah virus, compositions comprising said vectors and/or Hendra virus polypeptides, methods of vaccination against Hendra virus and Nipah virus, and kits for use with such methods and compositions.
    Type: Application
    Filed: August 10, 2016
    Publication date: March 30, 2017
    Applicant: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Jules Maarten Minke, Teshome Mebatsion, Catherine Charreyre
  • Publication number: 20170087230
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.
    Type: Application
    Filed: May 13, 2015
    Publication date: March 30, 2017
    Applicants: MERIAL INC., VITAMFERO S.A, L'Universite De Bourgogne, L'Institut National Superieur des Sciences Agronom iques de L'Alimentation et de L'Environment
    Inventors: Noel Yves Henri Jean Genin, Jean-Christophe Audonnet, Didier Roy, Edouard Seche, Patrick Gervais, Samira Khaldi-Plassart, Romain Useo, Joelle DeConinck
  • Patent number: 9555101
    Abstract: The present invention provides compositions or vaccines that contain a recombinant EHV-1 that elicit an immune response in animals against equine herpesvirus, including compositions comprising the recombinant EHV-1, methods of vaccination against equine herpesvirus, and kits for use with such methods and compositions.
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: January 31, 2017
    Assignee: Merial, Inc.
    Inventors: Jean Christophe Audonnet, Jules Maarten Minke, Nikolaus Osterrieder, Guanggang Ma
  • Publication number: 20170022255
    Abstract: The present invention encompasses BTV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing BTV antigens. The invention also encompasses recombinant vectors encoding and expressing BTV antigens, epitopes or immunogens which can be used to protect animals, such as ovines, bovines, or caprines, against BTV.
    Type: Application
    Filed: April 14, 2016
    Publication date: January 26, 2017
    Applicant: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Xuan Guo, Kevin Cox
  • Publication number: 20160220659
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Application
    Filed: September 23, 2015
    Publication date: August 4, 2016
    Applicant: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Zahia Hannas-Djebbara, Teshome Mebatsion, Yu-Wei Chiang, Justin Widener, Frédéric Reynard
  • Publication number: 20160199483
    Abstract: The present invention provides vectors that contain and express in vivo or in vitro CDV polypeptides or antigens that elicit an immune response in animal against CDV, compositions comprising said vectors and/or CDV polypeptides, and methods of vaccination against CDV. The invention further provides methods for inducing an immunogenic or protective response against CDV and other canine virus, as well as methods for preventing or treating CDV and other canine virus or disease state(s) caused by CDV and other canine virus.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 14, 2016
    Applicant: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Jules Minke
  • Patent number: 9345759
    Abstract: The present invention encompasses BTV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing BTV antigens. The invention also encompasses recombinant vectors encoding and expressing BTV antigens, epitopes or immunogens which can be used to protect animals, such as ovines, bovines, or caprines, against BTV.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: May 24, 2016
    Assignee: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Xuan Guo, Kevin Cox
  • Patent number: 9327137
    Abstract: The present invention provides vectors that contain and express in vivo or in vitro CDV polypeptides or antigens that elicit an immune response in animal against CDV, compositions comprising said vectors and/or CDV polypeptides, and methods of vaccination against CDV. The invention further provides methods for inducing an immunogenic or protective response against CDV and other canine virus, as well as methods for preventing or treating CDV and other canine virus or disease state(s) caused by CDV and other canine virus.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: May 3, 2016
    Assignee: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Jules Minke
  • Publication number: 20150190502
    Abstract: The present invention provides compositions or vaccines that contain a recombinant EHV-1 that elicit an immune response in animals against equine herpesvirus, including compositions comprising said recombinant EHV-1, methods of vaccination against equine herpesvirus, and kits for use with such methods and compositions.
    Type: Application
    Filed: November 17, 2014
    Publication date: July 9, 2015
    Applicant: MERIAL LIMITED
    Inventors: Jean Christophe Audonnet, Jules Maarten Minke, Nikolaus Osterrieder, Guanggang Ma
  • Patent number: 8916371
    Abstract: The present invention provides compositions or vaccines that contain a recombinant EHV-1 that elicit an immune response in animals against equine herpesvirus, including compositions comprising said recombinant EHV-1, methods of vaccination against equine herpesvirus, and kits for use with such methods and compositions.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 23, 2014
    Assignee: Merial Limited
    Inventors: Jean Christophe Audonnet, Jules Maarten Minke, Nikolaus Osterrieder, Guanggang Ma